APSR2026-600

 
Late-Breaking
Submitted
Poster Presentation
 
AP16-004
P120
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220939-46904-Multicenter Retrospective Study_433213.pdf
Format: PDF Only
15. Pulmonary Circulation
12

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Javzan-Orlom Dorjjugder * The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Chuluunbileg Batbold - Institute Of Medical Sciences Internal Medicine Ulaanbaatar Mongolia
Gantogtokh Dashjamts - Institute Of Medical Sciences Internal Medicine Ulaanbaatar Mongolia
Munkh-Erdene Dashzeveg - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Zolzaya Batbold - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Enkh-Amgalan Tserendorj - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Altankhuyag Nergui - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Amgalandari Byambabaatar - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Enkhtuguldur Myagmar-Ochir - Mongolian National University of Medical Sciences Epidemiology and Biostatistics Ulaanbaatar Mongolia
Badamsed Tserendorj - The Third State Central Hospital Radiology Ulaanbaatar Mongolia
Tumur-Ochir Tsedev-Ochir - The Third State Central Hospital Pulmonology Ulaanbaatar Mongolia
Solongo Bandi - Mongolian National University of Medical Sciences Pulmonology and Allergy Ulaanbaatar Mongolia
 
 
 
Presenting Author Details
Javzan-Orlom
Dorjjugder
javzaa.shastin@yahoo.com
+976+97699083567
51-60
Mongolia
Original Research
Clinical Characteristics and Disease Severity of Pulmonary Embolism Among Mongolian Patients: Multicenter Retrospective Study
Maximum 25 words
Abstract Content
Pulmonary embolism is a major contributor to the global disease burden. In Mongolia, the exact prevalence and Mongolian-specific characteristics couldn't be addressed. To address geographical variation and ethnic-specific characteristics, we aimed to determine incidence and clinical characteristics in the Mongolian population.
This retrospective, multi-center study included a total of 232 patients who were admitted to the tertiary care hospitals, including the First Central Hospital, the State Second Central Hospital, and the Third State Central Hospital between January 01, 2020, and April 01, 2025. The information was collected from patient histories, including demographic information, risk factors, comorbidities, symptoms, and physical examination findings. Laboratory analyses included complete blood count, coagulation, and biochemical parameters. We used the Pulmonary Embolism Severity Index to determine disease severity.
The mean age of participants was 57±17 years, 55.2% (128) were men. The most common symptoms were dyspnea (90.9%), chest pain (74.2%), cough (70.5%), leg pain (38.9%), and hemoptysis (20.7%). 20.7% (n=48) were at high risk of death within 30 days (Class IV-V) with no significant difference by sex, BMI categories, and the presence of DVT. However, patients with comorbidity and aged over 65 years had significantly higher rates in the class IV-V group than the I-III group (p<0.05). Moreover, patients in the class IV-V group more frequently experienced hemoptysis and severe dyspnea (P<0.05). Patients in the IV-IV group had significantly higher leukocyte count and lower serum protein level compared with those in the PESI I–III groups. Significant linear correlations were observed between the PESI score and leukocyte count (r = 0.263), hematocrit (r = 0.138), neutrophil count (r = 0.156), neutrophil-to-lymphocyte ratio (r = 0.187), and platelet-to-lymphocyte ratio (r = 0.165). In contrast, negative correlations were observed between the PESI score and platelet count (r = −0.169), lymphocyte count (r = −0.205), and serum protein level (r = −0.374).
Dyspnea, chest pain, and cough were the most common symptoms among patients diagnosed with acute pulmonary embolism. Approximately one-quarter of the participants were evaluated as PESI class IV-V. The PESI score was significantly associated with the inflammatory level.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Gender, Age, Symptom, PESI score
maximum 3 keywords and no abbreviations, separated by commas
The authors declare there is no acknowledgement in this study.
354